G09 CARDI-MET
Active substance: ADENOSINE TRIPHOSPHATE, CALCIUM FLUORIDE, SODIUM SULFATE, STROPHANTHUS HISPIDUS SEED, CRATAEGUS LAEVIGATA FRUIT, FERROSOFERRIC PHOSPHATE, GELSEMIUM SEMPERVIRENS ROOT, PANCRELIPASE LIPASE
SOLUTION/ DROPS · ADENOSINE TRIPHOSPHATE 5 [hp_X]/mL, CALCIUM FLUORIDE 7 [hp_C]/mL, SODIUM SULFATE 1 [hp_Q]/mL, STROPHANTHUS HISPIDUS SEED 7 [hp_C]/mL, CRATAEGUS LAEVIGATA FRUIT 7 [hp_C]/mL, FERROSOFERRIC PHOSPHATE 1 [hp_Q]/mL, GELSEMIUM SEMPERVIRENS ROOT 1 [hp_Q]/mL, PANCRELIPASE LIPASE 7 [hp_C]/mL
United StatesActive
Marketing holder: Apex Energetics Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ADENOSINE TRIPHOSPHATE · 5 [hp_X]/mL
- CALCIUM FLUORIDE · 7 [hp_C]/mL
- SODIUM SULFATE · 1 [hp_Q]/mL
- STROPHANTHUS HISPIDUS SEED · 7 [hp_C]/mL
- CRATAEGUS LAEVIGATA FRUIT · 7 [hp_C]/mL
- FERROSOFERRIC PHOSPHATE · 1 [hp_Q]/mL
- GELSEMIUM SEMPERVIRENS ROOT · 1 [hp_Q]/mL
- PANCRELIPASE LIPASE · 7 [hp_C]/mL
Registration
- Registration number
- 63479-0709
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 63479-0709 · Verified 2026-10-09 · open in source